Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
Rays of Belief Reports Q1 FY27 Revenue of ₹25.31 Cr (Up 136.5% YoY), PAT at ₹2.79 Cr
Rays of Belief Limited (Mom's Belief) issued a press release detailing its unaudited financial results for Q1 FY27 (quarter ended June 30, 2026). Revenue from operations grew 136.45% YoY to ₹253.14 Mn (₹25.31 Cr). Operating EBITDA jumped 865.21% YoY to ₹50.77 Mn with EBITDA margins expanding 1,515 bps to 20.06%. The company achieved a turnaround to profitability with a net profit of ₹27.87 Mn (₹2.79 Cr), delivering an EPS of ₹1.78 for the quarter.
high confidence
What changedRays of Belief announced a sharp turnaround to profitability in Q1 FY27 alongside a 136.45% YoY surge in operating revenues.
Why it mattersThe company demonstrated high operational leverage in its therapy centre model, expanding EBITDA margins by over 1,500 bps and generating positive free cash flow potential.
📅 Short termThe significant turnaround in earnings and margin expansion is likely to be viewed favorably in near-term trading.
📈 Long termSustained revenue growth depends on scaling its 136 therapy centres, increasing capacity utilization, and executing specialized developmental-care programs.
⚠ Risk flags
Sustainability of operating margins post-turnaround
Regulatory and compliance risks in pediatric and specialized healthcare services
👀 What to Watch
Track whether the strong margin expansion (EBITDA margin of 20.06%) can be sustained in upcoming quarters and monitor centre-expansion metrics.
MOMSBELIEF Q1 FY27 Cons PAT at Rs 27.87 Mn vs Loss YoY; Acquires City Pro Group
Rays of Belief Limited (Moms Belief) reported its Q1 FY27 results, showing consolidated revenue from operations jump 136.4% YoY to INR 253.14 million compared to INR 107.06 million in Q1 FY26. Consolidated profit after tax turned around to INR 27.87 million from a net loss of INR 5.37 million in the year-ago quarter. The company noted that its US subsidiary acquired 100% of City Pro Group Inc. effective September 18, 2026. Standalone revenue grew 27.3% YoY to INR 124.91 million with PAT of INR 14.19 million.
high confidence
What changedReported strong Q1 FY27 turnaround earnings post-listing and completed the 100% acquisition of US-based City Pro Group Inc.
Why it mattersDemonstrates rapid expansion in the US therapy services market, which now contributes more than half of consolidated revenues and drove the turnaround from loss to profit.
📅 Short termPositive sentiment likely driven by the robust swing into profitability and post-quarter acquisition disclosure.
📈 Long termExpansion into the US healthcare and neurodevelopmental therapy market via acquisitions offers high revenue potential, subject to execution and cross-border regulatory integration.
⚠ Risk flags
Integration risk associated with the 100% acquisition of City Pro Group Inc.
Prior year Q1 comparative figures were not audited or reviewed by statutory auditors as the firm was unlisted
👀 What to Watch
Track the integration and financial impact of the City Pro Group Inc. acquisition in upcoming quarters, as well as the sustainability of operating margins in the US segment.
Rays of Belief Acquires US-Based City Pro Group with FY25 Revenue of US$11.43M (~₹97.27 Cr)
Rays of Belief Limited (Mom's Belief) has completed the 100% acquisition of New York-based pediatric healthcare provider City Pro Group Inc. (CPG) through its US subsidiary, effective September 18, 2026. CPG generated revenue of US$11.43 million (~₹97.27 crore) in FY25, which exceeds Mom's Belief's own FY26 consolidated revenue of ₹81.66 crore (119% of standalone scale). The transaction significantly scales the company's footprint into the US early intervention market while complementing its existing network of 136 centres in India.
high confidence
What changedRays of Belief has fully acquired City Pro Group Inc. via its subsidiary Mom's Belief US Inc., making CPG a step-down wholly owned subsidiary.
Why it mattersThe acquisition more than doubles the company's consolidated revenue run-rate (adding ~₹97.27 Cr to ₹81.66 Cr base) and gives immediate access to the US Medicaid and New York Early Intervention market.
Target FY25 Revenue: US$11.43 million (~₹97.27 Cr)Acquirer FY26 Revenue: ₹81.66 CrTarget Revenue vs Acquirer FY26 Revenue: ~119.1%Acquirer FY26 Net Profit: ₹4.96 CrAcquisition Stake: 100%
📅 Short termPositive sentiment is expected due to the transformative size of the revenue addition, though the deal valuation and acquisition cost remain undisclosed.
📈 Long termPositions the company as a cross-border pediatric developmental care platform with exposure to US dollar revenues alongside its 136-centre domestic network.
⚠ Risk flags
Acquisition consideration and funding structure not disclosed in the filing
Integration risks across cross-border healthcare regulatory regimes (New York State Medicaid)
Profitability metrics of City Pro Group were not specified
👀 What to Watch
Track subsequent disclosures regarding the transaction's purchase consideration, funding mix (debt vs equity dilution), and operating margins of the acquired US business in upcoming quarterly results.
MOMSBELIEF Acquires US-Based City Pro Group for USD 2 Million
Rays of Belief Limited announced that its wholly owned US subsidiary, Mom's Belief US Inc., has acquired 100% equity shareholding in City Pro Group Inc. for a cash consideration of USD 2,000,000. City Pro Group is a New York-based provider of pediatric early intervention and special education services, reporting a turnover of USD 11,432,394.52 for the fiscal year ended June 30, 2025. The transaction was completed with effect from September 18, 2026, without requiring further governmental or regulatory approvals. This acquisition aims to significantly expand the group's footprint in pediatric developmental services within the US market.
high confidence
What changedCity Pro Group Inc. has become a 100% step-down wholly owned subsidiary of Rays of Belief Limited effective September 18, 2026.
Why it mattersAdds over USD 11.4 million in annual revenue and establishes an operational base in New York clinics and school-based early intervention services.
📅 Short termMarket may view the transaction positively due to the attractive valuation multiple (USD 2M consideration vs USD 11.4M revenue).
📈 Long termEnhances cross-border capabilities in pediatric therapy and special education, positioning the company to scale within US healthcare and Medicaid-funded programs.
⚠ Risk flags
Cross-border integration risks and regulatory compliance with New York State Medicaid and NYC Department of Education contracts.
👀 What to Watch
Monitor upcoming quarterly consolidated financials to assess integration costs, revenue accretion from the US operations, and operational margin impact.
Rays of Belief Invests $2M (~₹19.19 Cr) in Wholly Owned US Subsidiary via Rights Issue
Rays of Belief Limited has made an additional investment of USD 2,000,000 (approximately ₹19.19 crore) in its wholly owned subsidiary, Mom's Belief US Inc., via a rights issue at par value (USD 1 per share). The funding fulfills the objects outlined in the company's IPO prospectus dated September 08, 2026. Mom's Belief US Inc., which was incorporated in April 2025 and operates in allergy and immunology services, reported a turnover of USD 38,25,615 for FY 2025-26. Rays of Belief will continue to hold 100% shareholding in the entity following the transaction.
high confidence
What changedRays of Belief deployed ₹19.19 crore of capital into its wholly owned US subsidiary via a rights issue.
Why it mattersThe capital injection funds the subsidiary's specialised healthcare infrastructure (allergy and immunology) pursuant to stated IPO prospectus objectives.
📅 Short termNeutral; this is an expected capital deployment in line with stated IPO objectives dated September 08, 2026.
📈 Long termSuccess hinges on scaling specialized US healthcare services and expanding international revenue contribution.
⚠ Risk flags
Execution risk in scaling healthcare operations in the US market
Foreign exchange fluctuation risks under FEMA regulations
👀 What to Watch
Monitor how efficiently the deployed ₹19.19 crore translates into operational expansion and US subsidiary top-line growth in upcoming financial reports.
📊 Last 7 days — analysed filings by sentiment
positivenegativeneutralwatch
⚠️How this site is made: Market data pages are computed automatically from NSE/BSE publications and company filings; news articles and announcement analyses are written with AI assistance, with a human in the loop: our editors review what the AI produces. Both can contain errors. Verify with the original sources before any investment decision. Not investment advice; Flash Finance is not SEBI-registered. How we use AI
⚡ Free FlashFinance Newsletters
AI-powered market intelligence in your inbox — completely free. Pick your topics; max 1 email per topic per day. Unsubscribe anytime.
✅ Everything below is 100% free — no payment, no card, ever.
🎉
You're subscribed!
A welcome email with your topics is on its way. Want it even faster? Join us on Telegram or WhatsApp:
